{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:45:23Z","timestamp":1761864323003,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100010014","name":"Six Talent Peaks Project in Jiangsu Province","doi-asserted-by":"publisher","award":["2016-WSN-098"],"award-info":[{"award-number":["2016-WSN-098"]}],"id":[{"id":"10.13039\/501100010014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009156","name":"Nantong Science and Technology Bureau","doi-asserted-by":"publisher","award":["JC2020046","JC2020047","MS22019005","MA2020024"],"award-info":[{"award-number":["JC2020046","JC2020047","MS22019005","MA2020024"]}],"id":[{"id":"10.13039\/501100009156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s13300-021-01107-w","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T09:03:21Z","timestamp":1627981401000},"page":"2437-2450","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Shift of Glucose Peak Time During Oral Glucose Tolerance Test is Associated with Changes in Insulin Secretion and Insulin Sensitivity After Therapy with Antidiabetic Drugs in Patients with Type\u00a02 Diabetes"],"prefix":"10.1007","volume":"12","author":[{"given":"Yanqiu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiwei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"OuYang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranran","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1887-9992","authenticated-orcid":false,"given":"Yunjuan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8658-223X","authenticated-orcid":false,"given":"Xinlei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,3]]},"reference":[{"issue":"3","key":"1107_CR1","first-page":"E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214\u201323.","journal-title":"Am J Physiol"},{"issue":"8","key":"1107_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11892-018-1023-3","volume":"18","author":"ME Chen","year":"2018","unstructured":"Chen ME, Aguirre RS, Hannon TS. Methods for measuring risk for type\u00a02 diabetes in youth: the oral glucose tolerance test (OGTT). Curr Diab Rep. 2018;18(8):51.","journal-title":"Curr Diab Rep"},{"issue":"6","key":"1107_CR3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0939-4753(04)80027-9","volume":"14","author":"F Leonetti","year":"2004","unstructured":"Leonetti F, Iacobellis G, Zappaterreno A, et al. Insulin sensitivity assessment in uncomplicated obese women: comparison of indices from fasting and oral glucose load with euglycemic hyperinsulinemic clamp. Nutr Metab Cardiovasc Dis. 2004;14(6):366\u201372.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"12","key":"1107_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1301\/nr.2003.dec.397-412","volume":"61","author":"LU Monzillo","year":"2003","unstructured":"Monzillo LU, Hamdy O. Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev. 2003;61(12):397\u2013412.","journal-title":"Nutr Rev"},{"issue":"3","key":"1107_CR5","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2337\/diacare.24.3.539","volume":"24","author":"A Mari","year":"2001","unstructured":"Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care. 2001;24(3):539\u201348.","journal-title":"Diabetes Care"},{"issue":"9","key":"1107_CR6","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.metabol.2007.04.002","volume":"56","author":"M-E Pich\u00e9","year":"2007","unstructured":"Pich\u00e9 M-E, Lemieux S, Corneau L, Nadeau A, Bergeron J, Weisnagel SJ. Measuring insulin sensitivity in postmenopausal women covering a range of glucose tolerance: comparison of indices derived from the oral glucose tolerance test with the euglycemic-hyperinsulinemic clamp. Metabolism. 2007;56(9):1159\u201366.","journal-title":"Metabolism"},{"issue":"4","key":"1107_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1368-5031.2005.00422.x","volume":"59","author":"M Kanauchi","year":"2005","unstructured":"Kanauchi M, Kimura K, Kanauchi K, Saito Y. Beta-cell function and insulin sensitivity contribute to the shape of plasma glucose curve during an oral glucose tolerance test in non-diabetic individuals. Int J Clin Pract. 2005;59(4):427\u201332.","journal-title":"Int J Clin Pract"},{"issue":"4","key":"1107_CR8","doi-asserted-by":"publisher","first-page":"R941","DOI":"10.1152\/ajpregu.00650.2010","volume":"300","author":"A Tura","year":"2011","unstructured":"Tura A, Morbiducci U, Sbrignadello S, Winhofer Y, Pacini G, Kautzky-Willer A. Shape of glucose, insulin, C-peptide curves during a 3-h oral glucose tolerance test: any relationship with the degree of glucose tolerance? Am J Physiol Regul Integr Comp Physiol. 2011;300(4):R941\u20138.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1107_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.metabol.2017.02.007","volume":"70","author":"M Manco","year":"2017","unstructured":"Manco M, Nolfe G, Pataky Z, Winhofer Y, Pacini G, Kautzky-Willer A. Shape of the OGTT glucose curve and risk of impaired glucose metabolism in the EGIR-RISC cohort. Metabolism. 2017;70:42\u201350.","journal-title":"Metabolism"},{"issue":"6","key":"1107_CR10","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1111\/jdi.12834","volume":"9","author":"X Wang","year":"2018","unstructured":"Wang X, Zhao X, Zhou R, et al. Delay in glucose peak time during the oral glucose tolerance test as an indicator of insulin resistance and insulin secretion in type\u00a02 diabetes patients. J Diabetes Investig. 2018;9(6):1288\u201395.","journal-title":"J Diabetes Investig"},{"issue":"1","key":"1107_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.diabres.2014.04.023","volume":"105","author":"CK Kramer","year":"2014","unstructured":"Kramer CK, Vuksan V, Choi H, Zinman B, Retnakaran R. Emerging parameters of the insulin and glucose response on the oral glucose tolerance test: reproducibility and implications for glucose homeostasis in individuals with and without diabetes. Diabetes Res Clin Pract. 2014;105(1):88\u201395.","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"1107_CR12","doi-asserted-by":"publisher","first-page":"E287","DOI":"10.1152\/ajpendo.00374.2017","volume":"314","author":"S Tran","year":"2018","unstructured":"Tran S, Kramer CK, Zinman B, Choi H, Retnakaran R. Effect of chronic liraglutide therapy and its withdrawal on time to postchallenge peak glucose in type\u00a02 diabetes. Am J Physiol Endocrinol Metab. 2018;314(3):E287\u201395.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"1107_CR13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/cen.12199","volume":"80","author":"A Gastaldelli","year":"2014","unstructured":"Gastaldelli A, Brodows RG, D\u2019Alessio D. The effect of chronic twice daily exenatide treatment on \u03b2-cell function in new onset type\u00a02 diabetes. Clin Endocrinol (Oxf). 2014;80(4):545\u201353.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"1107_CR14","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1210\/jc.2018-00040","volume":"103","author":"PF Hsu","year":"2018","unstructured":"Hsu PF, Sung SH, Cheng HM, et al. Cardiovascular benefits of acarbose vs sulfonylureas in patients with type\u00a02 diabetes treated with metformin. J Clin Endocrinol Metab. 2018;103(10):3611\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1107_CR15","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/S0149-2918(01)80140-5","volume":"23","author":"RE Koledova","year":"2001","unstructured":"Koledova RE, Metcalfe S, Hultman C, Milicevic Z, Romania\/Russia Mix25 Study Group. Glycemic control with humalog Mix25 in type\u00a02 diabetes inadequately controlled with glyburide. Clin Ther. 2001;23(10):1732\u201344.","journal-title":"Clin Ther"},{"issue":"6","key":"1107_CR16","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modelling. Diabetes Care. 2004;27(6):1487\u201395.","journal-title":"Diabetes Care"},{"issue":"7","key":"1107_CR17","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1089\/jmf.2017.0114","volume":"21","author":"M Cortez-Navarrete","year":"2018","unstructured":"Cortez-Navarrete M, Mart\u00ednez-Abundis E, P\u00e9rez-Rubio KG, Gonz\u00e1lez-Ortiz M, Villar MM-D. Momordica charantia administration improves insulin secretion in type\u00a02 diabetes mellitus. J Med Food. 2018;21(7):672\u20137.","journal-title":"J Med Food"},{"issue":"1","key":"1107_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S2213-8587(15)00336-8","volume":"4","author":"JH Ohn","year":"2016","unstructured":"Ohn JH, Kwak SH, Cho YM, et al. 10-year trajectory of \u03b2-cell function and insulin sensitivity in the development of type\u00a02 diabetes: a community-based prospective cohort study. Lancet Diabetes Endocrinol. 2016;4(1):27\u201334.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"1107_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/dom.12128","volume":"16","author":"Y Liu","year":"2014","unstructured":"Liu Y, Hong T. Combination therapy of dipeptidyl peptidase-4 inhibitors and melformin in type\u00a02 diabetes: rationale and evidence. Diabetes Obes Metab. 2014;16(2):111\u20137.","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"1107_CR20","doi-asserted-by":"publisher","first-page":"346","DOI":"10.2337\/diab.33.4.346","volume":"33","author":"OG Kolterman","year":"1984","unstructured":"Kolterman OG, Gray RS, Shapiro G, Scarlett JA, Griffin J, Olefsky JM. The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects. Diabetes. 1984;33(4):346\u201354.","journal-title":"Diabetes"},{"issue":"Suppl 2","key":"1107_CR21","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1016\/0168-8227(91)90008-2","volume":"14","author":"DR Matthews","year":"1991","unstructured":"Matthews DR, Hosker JP, Stratton I. The physiological action of gliclazide: beta-cell function and insulin resistance. Diabetes Res Clin Pract. 1991;14(Suppl 2):S53\u20139.","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"1107_CR22","first-page":"195","volume":"28","author":"H Delgado","year":"2002","unstructured":"Delgado H, Lehmann T, Bobbioni-Harsch E, Ybarra J, Golay A. Acarbose improves indirectly both insulin resistance and secretion in obese type\u00a02 diabetic patients. Diabetes Metab. 2002;28(3):195\u2013200.","journal-title":"Diabetes Metab"},{"issue":"3","key":"1107_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","volume":"3","author":"DJ Drucker","year":"2006","unstructured":"Drucker DJ. The biology of incretin hormones. Cell Metab. 2006;3(3):153\u201365.","journal-title":"Cell Metab"},{"issue":"8","key":"1107_CR24","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.2337\/db09-0063","volume":"58","author":"M Cornu","year":"2009","unstructured":"Cornu M, Yang J-Y, Jaccard E, Poussin C, Widmann C, Thorens B. Glucagon-like peptide-1 protects beta-cells against apoptosis by increasing the activity of an IGF-2\/IGF-1 receptor autocrine loop. Diabetes. 2009;58(8):1816\u201325.","journal-title":"Diabetes"},{"issue":"12","key":"1107_CR25","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.2337\/dc14-0893","volume":"37","author":"R Retnakaran","year":"2014","unstructured":"Retnakaran R, Kramer CK, Choi H, et al. Liraglutide and the preservation of pancreatic b-cell function in early type\u00a02 diabetes: the LIBRA Trial. Diabetes Care. 2014;37(12):3270\u20138.","journal-title":"Diabetes Care"},{"key":"1107_CR26","doi-asserted-by":"crossref","unstructured":"Monnier L, Colette C. Postprandial and basal hyperglycaemia in type\u00a02 diabetes: contributions to overall glucose exposure and diabetic complications. Diabetes Metab. 2015;41(6):6S9\u20136S15.","DOI":"10.1016\/S1262-3636(16)30003-9"},{"issue":"11","key":"1107_CR27","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","volume":"3","author":"Diabetes Prevention Program Research Group","year":"2015","unstructured":"Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the diabetes prevention program outcomes study. Lancet Diabetes Endocrinol. 2015;3(11):866\u201375.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"1107_CR28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cmpb.2007.06.003","volume":"89","author":"K Thomaseth","year":"2008","unstructured":"Thomaseth K, Pavan A, Berria R, Glass L, DeFronzo R, Gastaldelli A. Model-based assessment of insulin sensitivity of glucose disposal and endogenous glucose production from double-tracer oral glucose tolerance test. Comput Methods Programs Biomed. 2008;89(2):132\u201340.","journal-title":"Comput Methods Programs Biomed"},{"issue":"11","key":"1107_CR29","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.metabol.2008.07.017","volume":"57","author":"C-H Hsieh","year":"2008","unstructured":"Hsieh C-H, Chung-Ze Wu, Hsiao F-C, et al. The impact of metabolic syndrome on insulin sensitivity, glucose sensitivity, and acute insulin response after glucose load in early-onset type\u00a02 diabetes mellitus: Taiwan Early-Onset Type\u00a02 Diabetes Cohort Study. Metabolism. 2008;57(11):1615\u201321.","journal-title":"Metabolism"},{"issue":"12","key":"1107_CR30","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1111\/dom.12357","volume":"16","author":"AS Rudenski","year":"2014","unstructured":"Rudenski AS, Hadden DR, Atkinson AB, et al. The interleukin-1 receptor antagonist anakinra improves first-phase insulin secretion and insulinogenic index in subjects with impaired glucose tolerance. Diabetes Obes Metab. 2014;16(12):1269\u201373.","journal-title":"Diabetes Obes Metab"},{"key":"1107_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13098-016-0131-y","volume":"8","author":"Y Kondo","year":"2016","unstructured":"Kondo Y, Harada N, Hamasaki A, et al. Sitagliptin monotherapy has better effect on insulinogenic index than glimepiride monotherapy in Japanese patients with type\u00a02 diabetes mellitus: a 52-week, multicenter, parallel-group randomized controlled trial. Diabetol Metab Syndr. 2016;8:15.","journal-title":"Diabetol Metab Syndr"},{"key":"1107_CR32","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2337\/dc12-1880","volume":"37","author":"CK Mulvey","year":"2014","unstructured":"Mulvey CK, McNeill AM, Girman CJ, et al. Differential associations of oral glucose tolerance test-derived measures of insulin sensitivity and pancreatic beta-cell function with coronary artery calcification and microalbuminuria in type\u00a02 diabetes. Diabetes Care. 2014;37:124\u201333.","journal-title":"Diabetes Care"},{"issue":"1","key":"1107_CR33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2337\/diabetes.54.1.166","volume":"54","author":"V Lyssenko","year":"2005","unstructured":"Lyssenko V, Almgren P, Anevski D, et al. Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type\u00a02 diabetes. Diabetes. 2005;54(1):166\u201374.","journal-title":"Diabetes"},{"issue":"2","key":"1107_CR34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2337\/dc08-1478","volume":"32","author":"KM Utzschneider","year":"2009","unstructured":"Utzschneider KM, Prigeon RL, Faulenbach MV, et al. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care. 2009;32(2):335\u201341.","journal-title":"Diabetes Care"},{"issue":"7258","key":"1107_CR35","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"IM Stratton","year":"2000","unstructured":"Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type\u00a02 diabetes (UKPDS 35): prospective observational study. Br Med J. 2000;321(7258):405\u201312.","journal-title":"Br Med J"},{"issue":"8","key":"1107_CR36","doi-asserted-by":"publisher","first-page":"968","DOI":"10.2337\/diab.44.8.968","volume":"44","author":"Diabetes Control and Complications Trial Research Group","year":"1995","unstructured":"Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes. 1995;44(8):968\u201383.","journal-title":"Diabetes"},{"issue":"1","key":"1107_CR37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2337\/db15-0893","volume":"65","author":"SS Thazhath","year":"2016","unstructured":"Thazhath SS, Marathe CS, Wu T, et al. The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type\u00a02 diabetes: a randomized controlled trial. Diabetes. 2016;65(1):269\u201375.","journal-title":"Diabetes"},{"issue":"8","key":"1107_CR38","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1210\/en.2011-0174","volume":"152","author":"SE Kanoski","year":"2011","unstructured":"Kanoski SE, Fortin SM, Arnold M, Grill JJ, Hayes MR. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4. Endocrinology. 2011;152(8):3103\u201312.","journal-title":"Endocrinology"},{"issue":"7","key":"1107_CR39","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.3390\/nu12071932","volume":"12","author":"C-Y Liu","year":"2020","unstructured":"Liu C-Y, Chang T-C, Lin S-H, Sheng-Tang Wu, Cha T-L, Tsao C-W. Metformin ameliorates testicular function and spermatogenesis in male mice with high-fat and high-cholesterol diet-induced obesity. Nutrients. 2020;12(7):1932.","journal-title":"Nutrients"},{"issue":"5","key":"1107_CR40","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/cells10050998","volume":"10","author":"TK Bo\u00dflau","year":"2021","unstructured":"Bo\u00dflau TK, Wasserfurth P, Kr\u00fcger B, et al. Abdominal obesity-related disturbance of insulin sensitivity is associated with CD8+ EMRA cells in the elderly. Cells. 2021;10(5):998.","journal-title":"Cells"},{"issue":"3","key":"1107_CR41","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/hep.29238","volume":"66","author":"X Zheng","year":"2017","unstructured":"Zheng X, Fen Xu, Liang H, et al. SIRT1\/HSF1\/HSP pathway is essential for exenatide-alleviated, lipid-induced hepatic endoplasmic reticulum stress. Hepatology. 2017;66(3):809\u201324.","journal-title":"Hepatology"},{"issue":"1","key":"1107_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1148\/radiol.12110772","volume":"264","author":"RW van der Meer","year":"2012","unstructured":"van der Meer RW, Lamb HJ, Smit JW, de Roos A. MR imaging evaluation of cardiovascular risk in metabolic syndrome. Radiology. 2012;264(1):21\u201337.","journal-title":"Radiology"},{"issue":"2","key":"1107_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00592-011-0295-8","volume":"50","author":"S Kouidhi","year":"2013","unstructured":"Kouidhi S, Berrhouma R, Rouissi K, et al. Human subcutaneous adipose tissue Glut 4 mRNA expression in obesity and type\u00a02 diabetes. Acta Diabetol. 2013;50(2):227\u201332.","journal-title":"Acta Diabetol"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-021-01107-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-021-01107-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-021-01107-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T09:06:30Z","timestamp":1672995990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-021-01107-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,3]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["1107"],"URL":"https:\/\/doi.org\/10.1007\/s13300-021-01107-w","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"type":"print","value":"1869-6953"},{"type":"electronic","value":"1869-6961"}],"subject":[],"published":{"date-parts":[[2021,8,3]]},"assertion":[{"value":"28 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}